# A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes

> **NCT02588950** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 11 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** U-500R

## Key facts

- **NCT ID:** NCT02588950
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-12
- **Primary completion:** 2017-05-25
- **Final completion:** 2017-05-25
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588950, "A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02588950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*